• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Diseases . Incidence of Myocardial Injury in COVID-19-Infected Patients: A Systematic Review and Meta-Analysis

tetano

Editor, Senior Moderator
Diseases


. 2020 Oct 27;8(4):E40.
doi: 10.3390/diseases8040040.
Incidence of Myocardial Injury in COVID-19-Infected Patients: A Systematic Review and Meta-Analysis


Narut Prasitlumkum[SUP] 1 [/SUP], Ronpichai Chokesuwattanaskul[SUP] 2 3 [/SUP], Charat Thongprayoon[SUP] 4 [/SUP], Tarun Bathini[SUP] 5 [/SUP], Saraschandra Vallabhajosyula[SUP] 6 [/SUP], Wisit Cheungpasitporn[SUP] 4 [/SUP]



Affiliations

Abstract

Introduction: The incidence of acute myocardial injury (AMI) among Coronavirus Disease 19 (COVID-19)-infected patients remain unclear. We aimed to conduct a systematic review and meta-analysis to further explore the incidence AMI in these patients. Methods: We comprehensively searched the MEDLINE, EMBASE and Cochrane databases from their inception to August 2020. The included studies were prospective or retrospective cohort studies that reported the event rate of AMI in COVID-19 patients. Data from each study were combined using random-effects to calculate the pooled incidence with 95% confidence intervals. Results: We identified twenty-seven studies consisting of 8971 hospitalized COVID-19-infected patients. The study demonstrated that 20.0% (95% CI 16.1-23.8% with substantial heterogeneity (I[SUP]2[/SUP] = 94.9%)) of hospitalized COVID-19 patients had AMI. In addition, our meta-regression suggested that older age, male and comorbidities were associated with a higher risk of AMI. Conclusion: The incidence of COVID-19-related myocardial injury ranges from 16.1-23.8%. Further larger studies are anticipated, as the pandemic is still ongoing.

Keywords: COVID-19; coronavirus; meta-analysis; myocardial injury; systematic review.
 
Back
Top Bottom